Search results
Results from the WOW.Com Content Network
AMAG Pharmaceuticals (AMAG) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of -4000.00% and 5.72%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
California State University, Fresno – The Daily Collegian; California State University, Fullerton – The Daily Titan; California State University, Long Beach – 22 West Magazine, Daily Forty-Niner and DIG magazine; California State University, Los Angeles – University Times; California State University, Monterey Bay – The Lutrinae
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
11 AMAG Austria Metall AG: AMAG certifies itself for the ASI Performance Standard. Retrieved December 17, 2018. 12 AMAG Austria Metall AG. In: Aluminium Stewardship Initiative. Retrieved December 17, 2018 (English). 13 AMAG Austria Metall AG: Annual Report 2018. In: www.amag-al4u.com. AMAG Austria Metall AG, February 28, 2019, accessed February ...